Mengis Capital Management, Inc. Amgen Inc Transaction History

Mengis Capital Management, Inc.

$487 Million
Q2 2024

A detailed history of Mengis Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 5,537 shares of AMGN stock, worth $1.77 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

5,537

Previous 5,662 2.21%

Holding current value

$1.77 Million

Previous $1.77 Million 2.2%

% of portfolio

0.36%

Previous 0.28%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $32,843 - $39,913	-125 Reduced 2.21%	5,537 $1.73 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $33,608 - $40,570	125 Added 2.26%	5,662 $1.61 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $6,392 - $7,211	-25 Reduced 0.45%	5,537 $1.59 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $655 - $814	-3 Reduced 0.05%	5,562 $1.49 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $119,776 - $141,633	-559 Reduced 9.13%	5,565 $1.24 Million
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $41,996 - $51,187	-186 Reduced 2.95%	6,124 $1.48 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $90,695 - $115,239	-396 Reduced 5.91%	6,310 $1.66 Million
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $33,669 - $37,972	-150 Reduced 2.19%	6,706 $1.51 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $21,917 - $24,390	-95 Reduced 1.37%	6,856 $1.67 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $341,622 - $377,924	-1,558 Reduced 18.31%	6,951 $1.68 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $211,210 - $241,711	-1,062 Reduced 11.1%	8,509 $1.91 Million
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $10,613 - $12,435	-50 Reduced 0.52%	9,571 $2.04 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $99,972 - $110,911	428 Added 4.66%	9,621 $2.35 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $5,547 - $6,465	-25 Reduced 0.27%	9,193 $2.29 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $121,172 - $144,295	560 Added 6.47%	9,218 $2.12 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $20,883 - $23,224	-89 Reduced 1.02%	8,658 $2.2 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $4,730 - $6,080	-25 Reduced 0.28%	8,747 $2.11 Million
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $55,018 - $65,923	316 Added 3.74%	8,772 $1.7 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $8,139 - $9,174	45 Added 0.54%	8,456 $1.61 Million
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $162,684 - $183,405	878 Added 11.66%	8,411 $1.74 Million
Q2 2018 Jul 24, 2018	BUY	$166.05 - $186.51 $31,881 - $35,809	192 Added 2.62%	7,533 $1.39 Million
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $132,833 - $155,232	-784 Reduced 9.65%	7,341 $1.25 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $212,675 - $237,623	1,260 Added 18.35%	8,125 $1.41 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $1.15 Million - $1.31 Million	6,865	6,865 $1.28 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

417M

Call Options Held

7.18M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.

Account

Mengis Capital Management, Inc. Amgen Inc Transaction History